Pharmaceutical Analysis & Statistics in Brazil, May 2013 (p2)

You might be interested in: therapeutics, drug, cancer, more »

31-80 of about 200 reports

Purchase Reports From Reputable Market Research Publishers

BRIC Contrast Media Injectors Market Outlook to 2020

BRIC Contrast Media Injectors Market Outlook to 2020

  • $ 3 000
  • Industry report
  • March 2014
  • by Global Data

BRIC Contrast Media Injectors Market Outlook to 2020 Summary GlobalData's new report, "BRIC Contrast Media Injectors Market Outlook to 2020", provides key market data on the BRIC Contrast Media Injectors ...

  • Industries : Drug Delivery Technology
  • Countries : Brazil, Russian Federation, India, China
Neupro (Parkinson's Disease) - Forecast and Market Analysis to 2022

Neupro (Parkinson's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Neupro (Parkinson's Disease) - Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural ...

  • Industries : Pathology
  • Countries : World, Brazil, United Kingdom, Spain, Italy, France, Germany, Japan, Europe, United States
Azilect (Parkinson's Disease) - Forecast and Market Analysis to 2022

Azilect (Parkinson's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Azilect (Parkinson's Disease) - Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural ...

  • Industries : Pathology
  • Countries : World, Brazil, United Kingdom, Spain, Italy, France, Germany, Europe, United States
Safinamide (Parkinson's Disease) - Forecast and Market Analysis to 2022

Safinamide (Parkinson's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Safinamide (Parkinson's Disease) - Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural ...

  • Industries : Pathology
  • Countries : World, Brazil, United Kingdom, Spain, Italy, France, Germany, Europe, United States
PharmaPoint: Parkinson's Disease - Brazil Drug Forecast and Market Analysis to 2022

PharmaPoint: Parkinson's Disease - Brazil Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • March 2014
  • by Global Data

PharmaPoint: Parkinson's Disease - Brazil Drug Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, ...

  • Industries : Pathology
  • Countries : Brazil
Madopar (Parkinson's Disease) - Forecast and Market Analysis to 2022

Madopar (Parkinson's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Madopar (Parkinson's Disease) - Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural ...

  • Industries : Pathology
  • Countries : World, Brazil, United Kingdom, Spain, Italy, France, Germany, Japan, Europe
Sinemet (Parkinson's Disease) - Forecast and Market Analysis to 2022

Sinemet (Parkinson's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Sinemet (Parkinson's Disease) - Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural ...

  • Industries : Pathology
  • Countries : World, Brazil, United Kingdom, Spain, Italy, France, Germany, Japan, Europe, United States
Stalevo/Comtan (Parkinson's Disease) - Forecast and Market Analysis to 2022

Stalevo/Comtan (Parkinson's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Stalevo/Comtan (Parkinson's Disease) - Forecast and Market Analysis to 2022 Summary Parkinson's disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and ...

  • Industries : Pathology
  • Countries : Brazil, Germany, Japan, World, United Kingdom, Europe, United States, Spain, Italy, France, Ireland
Brazil Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Brazil Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Brazil remains the most attractive emerging pharmaceutical industry in the Americas due to its large population, strong consumer demand, increasing urbanisation ...

  • Industries : Drug and Medication
  • Countries : Brazil
Latin American Bioinformatics Market by Sector (Agriculture, Molecular Medicine, Research & Animal), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) - Forecasts to 2017

Latin American Bioinformatics Market by Sector (Agriculture, Molecular Medicine, Research & Animal), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) - Forecasts to 2017

  • $ 4 650
  • Industry report
  • March 2014
  • by MarketsandMarkets

Bioinformatics is an integration of informatics and life sciences. It uses information technology, statistics, and algorithms for storing, retrieving, and analyzing biological data that is generated during ...

  • Industries : Drug Discovery and Development
  • Countries : United States, South America, Brazil, Chile, World, Argentina, Mexico, Peru, North America
MarketVIEW: Rabies vaccines

MarketVIEW: Rabies vaccines

  • $ 4 495
  • Industry report
  • March 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Rabies is a viral zoonosis caused by all members of the Lyssavirus genus and mostly spread by canine vectors. The disease, if untreated is 100% fatal, although almost 100% preventable through timely postexposure ...

  • Industries : Drug and Medication
  • Countries : China, World, Asia, India, Africa, South Africa, Brazil, Canada, Vietnam, Thailand, Philippines, United States, Europe, Sri Lanka, Indonesia, Bangladesh, Russian Federation, Nepal, Myanmar, Cambodia
Pharmaceuticals Market Analysis in Brazil: ISIC 2423

Pharmaceuticals Market Analysis in Brazil: ISIC 2423

  • $ 599
  • Industry report
  • January 2014
  • by Euromonitor International

Euromonitor International's Industrial reports provide a 360 degree view of an market . The Industrial industry report offers a comprehensive guide to the size and shape of the Pharmaceuticalsmarket at ...

  • Industries : Pharmaceutical
  • Countries : Brazil
Aspen Pharmacare Holdings Ltd (Symbol:APN) SWOT Analysis, Strategy, Revenues and Profits

Aspen Pharmacare Holdings Ltd (Symbol:APN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : Australia, South Africa, World, Brazil, Mexico, Germany, Tanzania, Kenya, Africa, Venezuela, Mauritius
Brazil Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Brazil Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2013
  • by Business Monitor International

BMI View: Brazil’s large population, combined with strong private consumption, bodes well for foreign drugmakers looking to capitalise on the growth trajectory of Latin America’s largest healthcare ...

  • Industries : Drug and Medication
  • Countries : Brazil
Emerging Technologies in Infectious Diseases Diagnostics (Technical Insights)

Emerging Technologies in Infectious Diseases Diagnostics (Technical Insights)

  • $ 6 500
  • Industry report
  • December 2013
  • by Frost & Sullivan

Infectious diseases diagnostics for the developing world This research service focuses on the emerging diagnostic technologies (for TB, HIV, HCV, HPV), the developmental initiatives, corporate developments ...

  • Industries : Pathology
  • Countries : World, United States, Brazil, India, China
EpiCast Report: Parkinson's Disease - Epidemiology Forecast to 2022

EpiCast Report: Parkinson's Disease - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • November 2013
  • by Global Data

EpiCast Report: Parkinson's Disease - Epidemiology Forecast to 2022 Summary Parkinson's disease is the second most common chronic progressive neurodegenerative disorder in the elderly after Alzheimer's ...

  • Industries : Pathology
  • Countries : Japan, Brazil, World, United States, Spain, Italy, France, Germany
Brazilian Pharmaceutical Market 2014-2024

Brazilian Pharmaceutical Market 2014-2024

  • $ 3 013
  • Industry report
  • November 2013
  • by Visiongain

Report Details Drug selling in Brazil - this new analysis shows you trends, opportunities, and revenues Do you want to assess the future of pharmaceuticals in Brazil? See what lies ahead, then. Visiongain's ...

  • Industries : Drug and Medication
  • Countries : Brazil
Empatic (Obesity) - Forecast and Market Analysis to 2022

Empatic (Obesity) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • October 2013
  • by Global Data

Empatic (Obesity) - Forecast and Market Analysis to 2022 Summary After a more than decade-long dormancy, the obesity market is undergoing a revival with the advent of several novel therapies that will ...

  • Industries : Pathology
  • Countries : World, Brazil, Canada, Spain, Italy, France, Germany, China, United States
Xenical (Obesity) - Forecast and Market Analysis to 2022

Xenical (Obesity) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • October 2013
  • by Global Data

Xenical (Obesity) - Forecast and Market Analysis to 2022 Summary After a more than decade-long dormancy, the obesity market is undergoing a revival with the advent of several novel therapies that will ...

  • Industries : Pathology
  • Countries : World, Brazil, Canada, Spain, Italy, France, Germany, China, United States
MediPoint: Renal Denervation - South American Analysis and Market Forecasts

MediPoint: Renal Denervation - South American Analysis and Market Forecasts

  • $ 4 450
  • Industry report
  • October 2013
  • by Global Data

MediPoint: Renal Denervation - South American Analysis and Market Forecasts Summary Numerous medical device news sources and industry executives have proclaimed renal denervation to be the top medical ...

  • Industries : Drug Discovery and Development
  • Countries : United States, South America, World, Brazil
Global Procedures for Fractures and Degenerative Disc Disease (North America, including Canada and the United States; Oceania, including Australia and New Zealand; Latin America, including Argentina, Mexico, Brazil and Other Countries; Europe, including G

Global Procedures for Fractures and Degenerative Disc Disease (North America, including Canada and the United States; Oceania, including Australia and New Zealand; Latin America, including Argentina, Mexico, Brazil and Other Countries; Europe, including G

  • $ 10 995
  • Industry report
  • October 2013
  • by iData Research, Inc.

Global Procedures for Fractures and Degenerative Disc Disease (North America, including Canada and the United States; Oceania, including Australia and New Zealand; Latin America, including Argentina, Mexico, ...

  • Industries : Pathology
  • Countries : World, Europe, South America, Australia, Argentina, North America, Brazil, Mexico, Oceania, Canada, Switzerland, Netherlands, Sweden, Spain, Portugal, Italy, Germany, Finland, Denmark, Belgium, Austria
Global Intravenous (IV) Iron Drugs Industry

Global Intravenous (IV) Iron Drugs Industry

  • $ 4 500
  • Industry report
  • October 2013
  • by Global Industry Analysts

This report analyzes the worldwide markets for Intravenous (IV) Iron Drugs in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, ...

  • Industries : Drug and Medication
  • Countries : World, United States, Europe, Japan, Germany, Canada, France, China, Spain, Russian Federation, Italy, India, Switzerland, North America, United Kingdom, South America, Brazil
PharmaPoint: Meningococcal Vaccines - Brazil Drug Forecast and Market Analysis to 2022

PharmaPoint: Meningococcal Vaccines - Brazil Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • September 2013
  • by Global Data

PharmaPoint: Meningococcal Vaccines - Brazil Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Meningococcal Vaccines - Brazil Drug Forecast ...

  • Industries : Drug and Medication
  • Countries : Brazil
Menveo (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Menveo (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • September 2013
  • by Global Data

Menveo (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset ...

  • Industries : Drug and Medication
  • Countries : Australia, World, Brazil, United States, Spain, Italy, France, Germany, Japan, Europe, United Kingdom, China, Oceania, South America
Nimenrix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Nimenrix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • September 2013
  • by Global Data

Nimenrix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset ...

  • Industries : Drug and Medication
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, Europe, Australia, United States, United Kingdom, China
Menitorix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Menitorix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • September 2013
  • by Global Data

Menitorix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset ...

  • Industries : Drug and Medication
  • Countries : Spain, World, Brazil, Italy, France, Germany, Japan, United Kingdom, Australia, Europe, United States, China
Meningitec (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Meningitec (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • September 2013
  • by Global Data

Meningitec (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset ...

  • Industries : Drug and Medication
  • Countries : World, Australia, Brazil, Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom, China, Oceania
Menjugate (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Menjugate (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • September 2013
  • by Global Data

Menjugate (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset ...

  • Industries : Drug and Medication
  • Countries : Brazil, World, Australia, Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom, China, South America, Oceania
NeisVac-C (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

NeisVac-C (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • September 2013
  • by Global Data

NeisVac-C (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset ...

  • Industries : Drug and Medication
  • Countries : World, Australia, Brazil, Spain, Italy, France, Germany, Japan, United Kingdom, Europe, United States, China, Oceania
Bexsero (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Bexsero (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • September 2013
  • by Global Data

Bexsero (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset ...

  • Industries : Drug and Medication
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, Australia, Europe, United States, United Kingdom, China
About 500 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description

  • Seroepidemiological Study of Herpes Simplex Virus Types 1 and 2 ...
  • September 2014
    6 pages
  • Pathology  

  • United Kingdom  

    Morocco  

    Sri Lanka  

View report >

Healthcare Analysis

April 2014

4 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

Abbott Laboratories

United States

Eli Lilly and Co.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.